Business Wire

Cognite Announces New Leaders to Continue Driving AI Innovation and Accelerate Industrial Value Realization

Share

Cognite, the global leader in industrial AI, today announced two strategic appointments to deliver more innovation with the AI ecosystem and customer value: Co-founder Geir Engdahl, as Chief Technology Officer, AI, and James Sirota as Global Head of Engineering. Engdahl will lead the company's AI First technology strategy. Sirota will spearhead the worldwide engineering functions, driving the rapid delivery of new capabilities and scaling of Cognite’s industrial AI and data platform Cognite Data Fusion® and the transformative industrial workbench Cognite Atlas AI™.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519865188/en/

James Sirota named Global Head of Engineering and Geir Engdahl, CTO, AI.

Since the company's founding, Engdahl has been pivotal in creating the only scalable and open AI platform specifically built for the demanding range and volume of industrial data. Cognite's unique architecture and capabilities have enabled customers to reap significant ROI from increasing production, reducing downtime, and accelerating sustainability. In this new role, he will return to his disruptive founder roots to extend Cognite's AI technology to deliver more real-time intelligence from any data, on any hyperscaler, and leveraging any LLM at scale.

Sirota joins Cognite as the company aggressively accelerates its delivery of intelligent, AI-powered applications to unlock the true potential of industrial data for decision-makers and domain experts across manufacturing, energy, and power generation verticals. Cognite's solutions are the key to enabling AI by liberating data from silos and making it AI-ready, forging a path towards real-time, scalable agentic AI-driven operations.

"Cognite is raising the bar on the next generation of AI First technology and development in order to help companies achieve more of their AI transformation goals and business outcomes. We welcome James to our executive team at such a transformative time for both Cognite and the industrial sector," said Girish Rishi, CEO at Cognite. "James' proven expertise in scaling engineering organizations and delivering AI-powered platforms, combined with Geir's innovation leadership and our previously announced CPO Chirayu Shah's product vision, will be vital as we continue to expand our global footprint and help industrial companies realize even more value from agentic AI, their industrial data and operations."

"I am thrilled to lead the charge for this next phase of AI innovation," said Geir Engdahl, CTO, AI at Cognite. "Being at the forefront and co-innovating with the global hyperscalers and LLM providers will unlock more value from agentic AI and all industrial data that are uniquely accessible in our platform."

Engdahl previously founded Snapsale in 2011, a classifieds AI startup. He led the company as CEO and CTO until the company was acquired by Schibsted in 2017. He also served as a senior software engineer for Google where he developed AI capabilities for targeting and conversion optimization in their advertising systems. Engdahl has a master's degree in computational science from the University of Oslo and received a silver medal from the International Olympiad in Informatics.

"Industrial enterprises generate enormous volumes of operational data, but often struggle to extract meaningful insights from it," said James Sirota, Global Head of Engineering at Cognite. "They need a robust platform to explore this data effectively, combined with powerful AI capabilities to identify trends and insights more efficiently. What drew me to Cognite was how their products address this exact challenge. Cognite is not only solving deeply technical problems—it's solving meaningful ones for the industrial sector. My job is to make sure our engineers are equipped, empowered, and inspired to deliver products that transform how the industrial sector works."

With over 20 years of leadership in software engineering and AI, Sirota brings a combination of technical depth and global execution excellence to Cognite. Having previously led engineering organizations at AWS, Cloudera, and Cisco, he brings extensive experience scaling enterprise software platforms and high-performing global teams. His passion for building cohesive, empowered engineering teams and high-scale platforms aligns directly with Cognite's vision. As the company continues its rapid global expansion, Sirota's leadership will be central to delivering innovative, AI-driven solutions that power the future of industry.

About Cognite

Cognite makes GenAI work for industry. Leading energy, manufacturing, and power & renewables enterprises choose Cognite to deliver secure, trustworthy, and real-time data to transform their asset-heavy operations to be safer, more sustainable, and profitable. Cognite provides a user-friendly, secure, and scalable platform that makes it easy for all decision-makers, from the field to remote operations centers, to access and understand complex industrial data, collaborate in real-time, and build a better tomorrow. Visit us at www.cognite.com and follow us on LinkedIn and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250519865188/en/

Contacts

Media Contact
Michelle Holford
Vice President, Global PR
michelle.holford@Cognite.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release

Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye